Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Tanja Stocks

Tanja Stocks


Tanja Stocks

Metabolic Syndrome and Endometrial Carcinoma


  • Tone Bjorge
  • Tanja Stocks
  • Annekatrin Lukanova
  • Steinar Tretli
  • Randi Selmer
  • Jonas Manjer
  • Kilian Rapp
  • Hanno Ulmer
  • Martin Almquist
  • Hans Concin
  • Goran Hallmans
  • Hakan Jonsson
  • Par Stattin
  • Anders Engeland

Summary, in English

The authors examined the association between the metabolic syndrome and risk of incident endometnal and fatal uterine corpus cancer within a large prospective cohort study Approximately 290,000 women from Austria, Norway, and Sweden were enrolled during 1974-2005, with measurements of height, weight, systolic and diastolic blood pressure, and circulating levels of glucose, total cholesterol, and tnglycendes Relative risks were estimated using Cox proportional hazards regression. The metabolic syndrome was assessed as a composite z score, as the standardized sum of z scores for body mass index, blood pressure, glucose, cholesterol, and tnglycendes. A total of 917 endonnetnal carcinomas and 129 fatal cancers were identified Increased risks of incident endometnal carcinoma and fatal uterine corpus cancer were seen for the metabolic syndrome factors combined, as well as for individual factors (except for cholesterol) The relative risk of endometnal carcinoma for the metabolic syndrome was 1.37 (95% confidence interval 1 28, 1 46) per 1-unit increment of z score The positive associations between metabolic syndrome factors (both individually and combined) and endometrial carcinoma were confined to the heaviest women. The association between the metabolic syndrome and endometnal carcinoma risk seems to go beyond the risk conferred by obesity alone, particularly in women with a high body mass index


  • EpiHealth: Epidemiology for Health
  • Surgery

Publishing year







American Journal of Epidemiology





Document type

Journal article


Oxford University Press


  • Public Health, Global Health, Social Medicine and Epidemiology


  • cohort studies
  • endometrial neoplasms
  • metabolic syndrome X



Research group

  • Surgery


  • ISSN: 0002-9262